Hemofenix France is a young company but with a solid foundation, makes innovation its flag: operates in the branch of therapeutic plasmapheresis and since its foundation adopts Hemofenix technology with membrane filter with remarkable results.
Plasmapheresis is the procedure of partial or total separation of the plasmatic fraction from the whole blood. Plasmapheresis can be carried out for therapeutic purposes in case of different clinical indications in nephrology, haematology, obstetrics and gynaecology,
ROSA™ plasma filter is made up of several overlapped porous membranes (Membrane Track) coated by nano-holes. Membranes and are made up by a thin polymeric film with holes, used for several applications in pharmacological, food, environmental-ecological, electronic, chemical and biotechnological fields.
Plasmapheresis can be performed for therapeutic purposes for different clinical indications in nephrology, hematology, obstetrics and gynecology, cardiology, surgery, neurology, oncology, dermatology, pediatrics.
The goal of therapeutic plasmapheresis is to remove some toxic substances to the body and cause disease.
The therapeutic apheresis is able to remove the circulating pathogenic solutes, but also to act to release the mononuclear phagocyte system (enhancing the endogenous removal of circulating pathogenic substances and the stimulation of lymphocyte clones, so as to make them more sensitive to cytotoxic chemotherapy), therefore, in addition to an action of an immunomodulating effect also presence removal.